Bristol-Myers Squibb: Bristol-Myers Squibb Company Reports Earnings Results for the First Quarter Ended March 31, 2025

Bristol-Myers Squibb Company reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported sales was USD 315 million compared to USD 306 million a year ago. Revenue was USD 11,201 million compared to USD 11,865 million a year ago. Net income was USD 2,456 million compared to net loss of USD 11,911 million a year ago. Basic earnings per share from continuing operations was USD 1.21 compared to basic loss per share from continuing operations of USD 5.89 a year ago. Diluted earnings per share from continuing operations was USD 1.2 compared to diluted loss per share from continuing operations of USD 5.89 a year ago. Bristol-Myers Squibb Company reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported sales was USD 315 million compared to USD 306 million a year ago. Revenue was USD 11,201 million compared to USD 11,865 million a year ago. Net income was USD 2,456 million compared to net loss of USD 11,911 million a year ago. Basic earnings per share from continuing operations was USD 1.21 compared to basic loss per share from continuing operations of USD 5.89 a year ago. Diluted earnings per share from continuing operations was USD 1.2 compared to diluted loss per share from continuing operations of USD 5.89 a year ago.